Wearable Health Solutions, Inc.
WHSI · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.15 | 0.00 | 0.00 |
| FCF Yield | -0.70% | -15.14% | -4.93% | -2.94% |
| EV / EBITDA | 22.33 | 56.07 | -9.07 | -11.63 |
| Quality | ||||
| ROIC | 9.92% | 35.80% | 66.08% | 50.35% |
| Gross Margin | 34.57% | 64.80% | 10.26% | 30.21% |
| Cash Conversion Ratio | -0.08 | -9.24 | 0.20 | 0.20 |
| Growth | ||||
| Revenue 3-Year CAGR | -21.67% | -20.48% | -18.47% | -16.28% |
| Free Cash Flow Growth | 94.13% | -61.68% | -1.75% | 78.93% |
| Safety | ||||
| Net Debt / EBITDA | 13.82 | 38.33 | -4.95 | -4.05 |
| Interest Coverage | -1.67 | -7.83 | -12.52 | -11.29 |
| Efficiency | ||||
| Inventory Turnover | 16.26 | 5.86 | 14.35 | 4.06 |
| Cash Conversion Cycle | -166.65 | -310.61 | -112.89 | -20.53 |